Short-term evaluation of motor and sensory nerve conduction parameters in COVID-19-associated peripheral neuropathy patients
Open Access
- 10 March 2023
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 17 (1) , 1-8
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) is mostly associated with upper and lower respiratory tract manifestations. However, coronavirus disease 19 (COVID-19) can result in a wide range of other systemic symptomatology, including neuropsychiatric, psychological, and psychosocial impairments. Literature regarding neurological compromise, including neuropathy and sensory and motor affection associated with COVID-19, is still limited. This study aims to evaluate the sensory, motor neuropathy, and secondary neurological impairment among patients with mild to moderate coronavirus disease associated with peripheral neuropathy within 1 month. Methods: Forty participants, including 20 mild to moderate COVID-19 patients with peripheral neuropathy and 20 age and gender-matched healthy volunteers, were recruited in this case/control study. Laboratory evaluation focused on C-reactive protein (CRP) and D-dimer levels. Oxygen saturation for all participants was recorded. The neurophysiological study included motor nerve study, sensory nerve study, and F wave study for upper and lower limbs were done. Results: The two groups were similar regarding baseline data. Neurological symptoms’ onset in the COVID-19 group ranged from 4 to 24 days. Levels of CRP and D-dimer levels were significantly higher in patients versus the control group. Motor nerve conduction (MNC) amplitude and latency for the median nerve were significantly compromised among the COVID-19 group. The MNC latency and F wave latency for the posterior tibial nerve were significantly higher in the COVID-19 group. The CRP and D-dimer levels were associated with a significant positive correlation with a latency of median nerve MNC, sensory nerve conduction (SNC), and f-wave; latency of MNC and F wave of the posterior tibial nerve; and SNC latency for sural nerve. Conclusion: neurological involvement can occur in mild to moderate cases of SARS-COV-2 infection and add to the burden of the disease. Neurological symptoms in the course of COVID-19 disease should be interpreted cautiously, and appropriate diagnosis, including nerve conduction studies and management, should be considered. Trial registration: ClinicalTrials.gov. NCT05721040.Keywords
This publication has 22 references indexed in Scilit:
- Nervous system involvement after infection with COVID-19 and other coronavirusesBrain, Behavior, and Immunity, 2020
- Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative ReviewInternational Journal of Environmental Research and Public Health, 2020
- Letter to the Editor Regarding the Viewpoint “Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanism”ACS Chemical Neuroscience, 2020
- Die COVID-19-Pandemie und das HNO-Fachgebiet: Worauf kommt es aktuell an?Laryngo-Rhino-Otologie, 2020
- Neurological Complications of Coronavirus Disease (COVID-19): EncephalopathyCureus, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trialCritical Care, 2020
- Potential neurological symptoms of COVID-19Therapeutic Advances in Neurological Disorders, 2020
- Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?Viruses, 2019
- Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesisVirus Research, 2014